首页> 外文期刊>Science in China. Series C, Life sciences >Keshan disease and mitochondrial cardiomyopathy
【24h】

Keshan disease and mitochondrial cardiomyopathy

机译:克山病和线粒体心肌病

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Keshan disease (KD) is a potentially fatal form of cardiomyopathy (disease of the heart muscle) endemic in certain areas of China. From 1984 to 1986, a national comprehensive scientific investigation on KD in Chuxiong region of Yunnan Province in the southwest China was conducted. The investigation team was composed of epidemiologists, clinic doctors, pathologists, biochemists, biophysicists and specialists in ecological environment. Results of pathological, biochemical and biophysical as well as clinical studies showed: an obvious increase of enlarged and swollen mitochondria with distended crista membranes in myocardium from patients with KD; significant reductions in the activity of oxidative phosphorylation (succinate dehydrogenase, cytochrome oxidase, succinate oxidase, H~+ -ATPase) of affected mitochondria; decrease in CoQ, cardiolipin, Se and GSHPx activity, while obvious increase in the Ca~(2+) content. So, it was suggested that mitochondria are the predominant target of the pathogenic factors of KD. Before Chuxiong KD survey only a few cases of mitochondrial cardiomyopathy were studied. During the multidisciplinary scientific investigation on KD in Chuxiong a large amount of samples from KD cases and the positive controls were examined. On the basis of the results obtained it was suggested that KD might be classified as a "Mitochondrial Cardiomyopathy" endemic in China. This is one of the achievements in the three years' survey in Chuxiong and is valuable not only to the deeper understanding of pathogenic mechanism of KD but also to the study of mitochondrial cardiomyopathy in general. Keshan disease is not a genetic disease, but is closely related to the malnutrition (especially microelement Se deficiency). KD occurs along a low Se belt, and Se supplementation has been effective in prevention of such disease. The incidence of KD has sharply decreased along with the steady raise of living standard and realization of preventive measures. At present, patients of KD are very sparse. In recent years the research on the non-KD mitochondrial cardiomyopathy has progressed rapidly. Given the advances in this aspect a minireview is written to evaluate the classification of KD as a kind of mitochondrial cardiomyopathy.
机译:克山病(KD)是中国某些地区特有的致命性心肌病(心肌病)。 1984年至1986年,对中国西南云南楚雄地区的KD进行了国家综合科学研究。调查小组由流行病学家,临床医生,病理学家,生物化学家,生物物理学家和生态环境专家组成。病理,生化,生物物理以及临床研究的结果表明:KD患者心肌线粒体肿胀和cr膜明显扩张。受影响的线粒体的氧化磷酸化活性(琥珀酸脱氢酶,细胞色素氧化酶,琥珀酸氧化酶,H〜+ -ATPase)显着降低; CoQ,心磷脂,Se和GSHPx活性降低,而Ca〜(2+)含量明显增加。因此,有人认为线粒体是KD的致病因素的主要靶标。在楚雄KD调查之前,仅研究了少数几例线粒体心肌病。在楚雄市对KD的多学科科学研究中,检查了来自KD病例和阳性对照的大量样本。根据获得的结果,建议在中国将KD归类为“线粒体心肌病”地方病。这是楚雄市三年来调查的成果之一,不仅对加深对KD的致病机制的了解,而且对线粒体性心肌病的研究均具有重要意义。克山病不是遗传疾病,但与营养不良(尤其是微量元素硒缺乏症)密切相关。 KD发生在低硒带,而硒的补充已有效预防这种疾病。随着人民生活水平的不断提高和预防措施的实现,KD的发病率急剧下降。目前,KD患者非常稀疏。近年来,非KD线粒体心肌病的研究进展迅速。鉴于在这方面的进展,撰写了一篇小型综述,以评估KD作为一种线粒体心肌病的分类。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号